Rasagiline for parkinsons disease modification

• 收藏
• 分享

专利权人:

Teva Pharmaceutical Industries; Ltd.

发明人:

Levy, Ruth,Eyal, Eli,Goren, Tamar,Oren, Sheila,Sayag, Naim,Weiss, Yonatan,Ben-Ami, Miri

申请号：

AU2016259315

公开号：

AU2016259315A1

申请日:

2016.11.15

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2016259315A120161201.pdf#####ABSTRACT A method for modifying Parkinsons disease by periodically administering a pharmaceutical composition comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt of rasagiline to the patient, thereby modifying the disease. The method includes reducing the rate of progression delaying the need for symptomatic anti-Parkinsonian therapy reducing the risk of a Parkinsons disease patient requiring symptomatic anti-Parkinsonian therapy and reducing the functional decline. 1

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/